Gastroparesis: Difference between revisions
No edit summary |
|||
| (30 intermediate revisions by 7 users not shown) | |||
| Line 1: | Line 1: | ||
==Background== | ==Background<ref>Parkman HP, Hasler WL, Fisher RS. American Gastroenterlogical Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004; 127(5): 1592-1622.</ref>== | ||
* | *Chronic GI disorder characterized by delayed gastric emptying ''without'' mechanical obstruction | ||
*More common in women | *More common in women, presumed due to elevated progesterone | ||
*Symptoms overlap with functional dyspepsia | |||
* | |||
==Causes of Non- | ===Causes of Non-Obstructive Delayed Gastric Emptying=== | ||
*Idiopathic | *Idiopathic (most common) | ||
*[[ | *[[Diabetes mellitus]] | ||
*Postsurgical/Vagal nerve injury | *Postsurgical/Vagal nerve injury | ||
*GI disorders associated with | *GI disorders associated with delayed emptying: | ||
**[[GERD]] | **[[GERD]], [[Achalasia]] | ||
**Atrophic [[gastritis]], celiac disease | |||
**Atrophic gastritis | **Functional [[dyspepsia]] | ||
**Functional dyspepsia | **Hypertrophic [[pyloric stenosis]] | ||
**Hypertrophic [[ | *Non-GI conditions/risk factors associated with delayed gastric emptying | ||
**Medications: [[opioids]], [[anticholinergics]], [[PPI]]s, [[alcohol]], tobacco, progesterone | |||
*Non-GI | **Eating disorders: [[Anorexia nervosa]] | ||
**Eating disorders: [[Anorexia]] | **[[Parkinson's disease]] and other neurologic disorders | ||
** | **[[Collagen vascular disease]] | ||
**Collagen vascular | **Parathyroid/[[thyroid disorder]] | ||
** | **Chronic renal insufficiency | ||
**Malignancy | |||
**Ischemic gastroparesis | |||
** | |||
** | |||
==Clinical Features== | ==Clinical Features== | ||
* | *Variable symptoms | ||
*Early satiety, bloating, upper abdominal discomfort | |||
* | *[[Nausea/vomiting]] | ||
* | *[[Abdominal pain]] (''not'' predominant symptom) | ||
*[[Dehydration]], [[malnutrition]] if longstanding disease | |||
* | |||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
=== | {{Nausea and vomiting DDX}} | ||
===Gastroparesis (by organ system)=== | |||
*[[Peptic ulcer disease]] | *GI | ||
*Mechanical Obstruction | **[[Peptic ulcer disease]] | ||
**Adhesion | **Mechanical Obstruction | ||
**[[Small bowel obstruction]]/LBO | ***Adhesion | ||
**Gastric outlet obstruction/[[Pyloric stenosis]] | ***[[Small bowel obstruction]]/LBO | ||
**[[Volvulus]] | ***Gastric outlet obstruction/[[Pyloric stenosis]] | ||
**Strangulated hernia | ***[[Volvulus]] | ||
*[[Pancreatitis]] | ***Strangulated [[hernia]] | ||
*[[Appendicitis]] | **[[Pancreatitis]] | ||
*[[Cholecystitis]] | **[[Appendicitis]] | ||
**[[Cholecystitis]], [[Cholangitis]] | |||
*[[Acute Hepatitis]] | **[[Acute Hepatitis]] | ||
*IBD | **[[IBD]] | ||
*[[Intussusception]] | **[[Intussusception]] | ||
*Malignancy | **Malignancy | ||
*[[Mesenteric ischemia]] | **[[Mesenteric ischemia]] | ||
*Esophageal disorders (e.g. achalasia, GERD, [[esophagitis]] | **Esophageal disorders (e.g. [[achalasia]], [[GERD]], [[esophagitis]]) | ||
*Functional disorders | **Functional disorders such as [[Irritable Bowel Syndrome]] | ||
** | *Neurologic | ||
**[[ | **[[Cannabinoid hyperemesis syndrome]] | ||
*Infectious | |||
**[[Spontaneous bacterial peritonitis]] | |||
**[[Urinary tract infection]] | |||
**[[bacterial disease|Bacterial]] toxins, [[viruses]] ([[adenovirus]], [[norovirus]], [[rotavirus]]) | |||
*Drugs/Toxins | |||
**[[Heavy metal toxicity]] | |||
**[[Methanol toxicity]] | |||
*Endocrine | |||
**[[Diabetic ketoacidosis]] | |||
**[[Thyroid disorder]] | |||
**Parathyroid disorders | |||
**[[Uremia]] | |||
*Miscellaneous | |||
**[[Anorexia nervosa]], [[Bulimia nervosa]] | |||
==== | ==Evaluation== | ||
*[[ | [[File:GastroparesisXray.jpg|thumb|Simple abdominal X-ray reveals a large amount of material in the stomach, suggesting severe gastric hypomotility.]] | ||
*Definitive diagnosis of gastroparesis not typically made in ED | |||
**Gold standard is gastric emptying scintigraphy of a solid-phase meal | |||
* | **Other studies assessing emptying: tests, upper GI barium study, ultrasound for changes in antral area | ||
*[[ | *ED workup to exclude alternative diagnoses and complications (e.g. [[dehydration]], [[Electrolyte abnormalities]]) | ||
*[[ | *CBC, BMP, [[LFTs]], lipase | ||
* | *[[Urinalysis]], uHCG | ||
*Consider: | |||
**[[ECG]] (if >50 or at risk for cardiac disease) | |||
* | **[[RUQ US]] | ||
* | **[[Acute abdominal series]] including an upright CXR (if risk for perforated ulcer) | ||
**CT abdomen/pelvis to rule out obstruction | |||
**Upper endoscopy or radiographic upper GI series to exclude mechanical obstruction or ulcer disease | |||
==== | ==Management== | ||
*[[ | ===ED Management=== | ||
* | *[[IVF]], [[Electrolyte repletion]] | ||
*[[ | *[[Antiemetics]] | ||
**Dopamine receptor antagonists: [[Haloperidol]], [[Prochlorperazine]], [[promethazine]], trimethobenzamide | |||
***[[Haloperidol]] has been shown to reduce the rate of admission and morphine equivalent doses of analgesia<ref>Ramirez R, Stalcup P, Croft B, Darracq MA. Haloperidol undermining gastroparesis symptoms (HUGS) in the emergency department. Am J Emerg Med. 2017;35(8):1118-1120. doi:10.1016/j.ajem.2017.03.015</ref> | |||
**[[Ondansetron]] | |||
*Prokinetic agents: enhance gut contractility | |||
**[[Metoclopramide]] | |||
***Also has antiemetic properties | |||
***PRN and/or standing dose prior to meals and bedtime | |||
**[[Erythromycin]] 125-350mg TID or QID | |||
*Refractory disease: | |||
**[[Nasogastric tube]] to decompress stomach | |||
**Advanced therapies (not in ED) may include: placement of jejunostomy and/or [[G-tube complications|gastrostomy tube]], pyloric injection of botulinum toxin, [[Gastric pacemaker complication|gastric electric stimulation]] | |||
*Prevention of future exacerbations: | |||
**Review medications, [[opioids]], [[anticholinergics]], [[PPI]]s may worsen or trigger symptoms | |||
**Avoid carbonated beverages, [[alcohol]], and [[tobacco]] | |||
**Optimize glycemic control in patients with [[diabetes]] ([[hyperglycemia]] alone can delay gastric emptying) | |||
**Dietary: smaller but more frequent meals, minimize fat/fiber, increase liquid nutrient component | |||
== | ==Complications== | ||
* | *[[Acute Gastric Dilation]] | ||
* | *[[Esophagitis]], [[Mallory-Weiss tear]] | ||
*[[Bezoar]] | |||
*[[Dehydration]], [[malnutrition]], [[electrolyte abnormalities]] | |||
* | |||
* | |||
==Disposition== | ==Disposition== | ||
*Discharge with outpatient follow up unless: | |||
**Inability to tolerate PO | |||
**Need for ongoing IV rehydration, electrolyte correction, and/or glycemic control | |||
==See Also== | ==See Also== | ||
*[[Diabetes mellitus]] | |||
*[[Nausea/vomiting]] | |||
==External Links== | ==External Links== | ||
| Line 96: | Line 123: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:GI]] | |||
Latest revision as of 00:49, 1 February 2024
Background[1]
- Chronic GI disorder characterized by delayed gastric emptying without mechanical obstruction
- More common in women, presumed due to elevated progesterone
- Symptoms overlap with functional dyspepsia
Causes of Non-Obstructive Delayed Gastric Emptying
- Idiopathic (most common)
- Diabetes mellitus
- Postsurgical/Vagal nerve injury
- GI disorders associated with delayed emptying:
- GERD, Achalasia
- Atrophic gastritis, celiac disease
- Functional dyspepsia
- Hypertrophic pyloric stenosis
- Non-GI conditions/risk factors associated with delayed gastric emptying
- Medications: opioids, anticholinergics, PPIs, alcohol, tobacco, progesterone
- Eating disorders: Anorexia nervosa
- Parkinson's disease and other neurologic disorders
- Collagen vascular disease
- Parathyroid/thyroid disorder
- Chronic renal insufficiency
- Malignancy
- Ischemic gastroparesis
Clinical Features
- Variable symptoms
- Early satiety, bloating, upper abdominal discomfort
- Nausea/vomiting
- Abdominal pain (not predominant symptom)
- Dehydration, malnutrition if longstanding disease
Differential Diagnosis
Nausea and vomiting
Critical
Emergent
- Acute radiation syndrome
- Acute gastric dilation
- Adrenal insufficiency
- Appendicitis
- Bowel obstruction/ileus
- Carbon monoxide poisoning
- Cholecystitis
- CNS tumor
- Electrolyte abnormalities
- Elevated ICP
- Gastric outlet obstruction, gastric volvulus
- Hyperemesis gravidarum
- Medication related
- Pancreatitis
- Peritonitis
- Ruptured viscus
- Testicular torsion/ovarian torsion
Nonemergent
- Acute gastroenteritis
- Biliary colic
- Cannabinoid hyperemesis syndrome
- Chemotherapy
- Cyclic vomiting syndrome
- ETOH
- Gastritis
- Gastroenteritis
- Gastroparesis
- Hepatitis
- Labyrinthitis
- Migraine
- Medication related
- Motion sickness
- Narcotic withdrawal
- Thyroid
- Pregnancy
- Peptic ulcer disease
- Renal colic
- UTI
Gastroparesis (by organ system)
- GI
- Peptic ulcer disease
- Mechanical Obstruction
- Adhesion
- Small bowel obstruction/LBO
- Gastric outlet obstruction/Pyloric stenosis
- Volvulus
- Strangulated hernia
- Pancreatitis
- Appendicitis
- Cholecystitis, Cholangitis
- Acute Hepatitis
- IBD
- Intussusception
- Malignancy
- Mesenteric ischemia
- Esophageal disorders (e.g. achalasia, GERD, esophagitis)
- Functional disorders such as Irritable Bowel Syndrome
- Neurologic
- Infectious
- Drugs/Toxins
- Endocrine
- Diabetic ketoacidosis
- Thyroid disorder
- Parathyroid disorders
- Uremia
- Miscellaneous
Evaluation
- Definitive diagnosis of gastroparesis not typically made in ED
- Gold standard is gastric emptying scintigraphy of a solid-phase meal
- Other studies assessing emptying: tests, upper GI barium study, ultrasound for changes in antral area
- ED workup to exclude alternative diagnoses and complications (e.g. dehydration, Electrolyte abnormalities)
- CBC, BMP, LFTs, lipase
- Urinalysis, uHCG
- Consider:
- ECG (if >50 or at risk for cardiac disease)
- RUQ US
- Acute abdominal series including an upright CXR (if risk for perforated ulcer)
- CT abdomen/pelvis to rule out obstruction
- Upper endoscopy or radiographic upper GI series to exclude mechanical obstruction or ulcer disease
Management
ED Management
- IVF, Electrolyte repletion
- Antiemetics
- Dopamine receptor antagonists: Haloperidol, Prochlorperazine, promethazine, trimethobenzamide
- Haloperidol has been shown to reduce the rate of admission and morphine equivalent doses of analgesia[2]
- Ondansetron
- Dopamine receptor antagonists: Haloperidol, Prochlorperazine, promethazine, trimethobenzamide
- Prokinetic agents: enhance gut contractility
- Metoclopramide
- Also has antiemetic properties
- PRN and/or standing dose prior to meals and bedtime
- Erythromycin 125-350mg TID or QID
- Metoclopramide
- Refractory disease:
- Nasogastric tube to decompress stomach
- Advanced therapies (not in ED) may include: placement of jejunostomy and/or gastrostomy tube, pyloric injection of botulinum toxin, gastric electric stimulation
- Prevention of future exacerbations:
- Review medications, opioids, anticholinergics, PPIs may worsen or trigger symptoms
- Avoid carbonated beverages, alcohol, and tobacco
- Optimize glycemic control in patients with diabetes (hyperglycemia alone can delay gastric emptying)
- Dietary: smaller but more frequent meals, minimize fat/fiber, increase liquid nutrient component
Complications
- Acute Gastric Dilation
- Esophagitis, Mallory-Weiss tear
- Bezoar
- Dehydration, malnutrition, electrolyte abnormalities
Disposition
- Discharge with outpatient follow up unless:
- Inability to tolerate PO
- Need for ongoing IV rehydration, electrolyte correction, and/or glycemic control
See Also
External Links
References
- ↑ Parkman HP, Hasler WL, Fisher RS. American Gastroenterlogical Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004; 127(5): 1592-1622.
- ↑ Ramirez R, Stalcup P, Croft B, Darracq MA. Haloperidol undermining gastroparesis symptoms (HUGS) in the emergency department. Am J Emerg Med. 2017;35(8):1118-1120. doi:10.1016/j.ajem.2017.03.015
